{"id":481267,"title":"Changes to notification requirements for biologic drugs: Notice to industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:17:00.389000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html?wbdisable=true","snippet":"Changes to notification requirements for biologic drugs: Notice to industry Health Canada is reducing the administrative burden to help clinical trial sponsors and market authorization holders efficiently distribute treatments. On this page Purpose and background Measures to…","rawSnapshotUrl":"/api/snapshots/raw/481267","browseUrl":"https://replay.healtharchive.ca/job-6/20260106161700/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/notice-notification-requirements-biologic-drugs.html?wbdisable=true#ha_snapshot=481267","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}